Simplex Trading, LLC Assembly Biosciences, Inc. Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$0.65 - $1.25 $47 - $91	73 New	73 $0
Q3 2022 Nov 04, 2022	SELL	$1.7 - $20.52 $5,071 - $61,211	-2,983 Reduced 52.46%	2,703 $4,000
Q2 2022 Aug 03, 2022	BUY	$1.35 - $2.29 $7,676 - $13,020	5,686 New	5,686 $11,000
Q1 2022 May 02, 2022	SELL	$1.46 - $2.45 $4,229 - $7,097	-2,897 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$2.13 - $3.46 $31,300 - $50,844	-14,695 Reduced 83.53%	2,897 $6,000
Q3 2021 Oct 28, 2021	BUY	$3.14 - $3.9 $628 - $780	200 Added 1.15%	17,592 $67,000
Q2 2021 Aug 12, 2021	SELL	$3.8 - $4.56 $16,780 - $20,136	-4,416 Reduced 20.25%	17,392 $67,000
Q1 2021 Apr 26, 2021	BUY	$4.33 - $6.63 $90,696 - $138,871	20,946 Added 2429.93%	21,808 $100,000
Q4 2020 Feb 02, 2021	BUY	$4.87 - $17.29 $4,197 - $14,903	862 New	862 $5,000
Q4 2019 Feb 05, 2020	SELL	$8.36 - $23.81 $7,716 - $21,976	-923 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$9.83 - $14.82 $10,183 - $15,353	-1,036 Reduced 52.88%	923 $9,000
Q2 2019 Jul 26, 2019	BUY	$12.9 - $20.8 $20,098 - $32,406	1,558 Added 388.53%	1,959 $26,000
Q1 2019 Apr 18, 2019	BUY	$17.7 - $24.93 $5,823 - $8,201	329 Added 456.94%	401 $0
Q4 2018 Jan 16, 2019	SELL	$19.05 - $36.45 $55,892 - $106,944	-2,934 Reduced 97.6%	72 $1,000
Q3 2018 Oct 23, 2018	BUY	$34.41 - $44.23 $3,131 - $4,024	91 Added 3.12%	3,006 $111,000
Q2 2018 Jul 30, 2018	BUY	$39.21 - $50.29 $56,109 - $71,964	1,431 Added 96.43%	2,915 $114,000
Q1 2018 Apr 26, 2018	SELL	$41.7 - $64.16 $452,862 - $696,777	-10,860 Reduced 87.98%	1,484 $72,000
Q4 2017 Jan 10, 2018	BUY	$28.58 - $49.91 $147,301 - $257,236	5,154 Added 71.68%	12,344 $558,000
Q3 2017 Oct 25, 2017	BUY	$23.08 - $34.92 $165,945 - $251,074	7,190	7,190 $251,000

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$277,028
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account